Vernessa Pollard has become a part of DLA Piper as a partner and co-chair of the FDA practice located in Washington, D.C. The firm made this announcement on a recent Thursday.
Pollard is known for representing clients in the life sciences, medical device, and technology industries, guiding them through FDA regulatory complexities to bring their products and technologies to market. This is a service declared by DLA Piper.
Before joining DLA Piper, Vernessa Pollard served as the associate chief counsel for enforcement, working in the Office of Chief Counsel of the FDA. This detail adds to the impressive repertoire that she brings to the firm.
This information was reported by Bloomberg Law Automation, offering a credible update on personnel movements within the legal field, particularly those with profound implications for FDA regulatory practice. Stay tuned to Bloomberg Law for updates on such critical shifts in the legal industry landscape.